Optiver Holding
AZN icon

Optiver Holding’s AstraZeneca AZN Stock Holding History

Optiver Holding’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.2M Sell
391,200
-135,800
-26% -$25.5M 0.02% 197
2026
Q1 		$104M Buy
527,000
+365,350
+226% +$70.4M 0.04% 122
2025
Q4 		$29.7M Sell
161,650
-76,350
-32% -$13.4M 0.01% 209
2025
Q3 		$36.5M Sell
238,000
-183,750
-44% -$27.8M 0.01% 169
2025
Q2 		$58.9M Buy
421,750
+172,300
+69% +$24.1M 0.03% 100
2025
Q1 		$36.7M Buy
249,450
+16,250
+7% +$2.35M 0.02% 114
2024
Q4 		$30.6M Buy
233,200
+119,600
+105% +$16.7M 0.02% 124
2024
Q3 		$17.7M Sell
113,600
-97,550
-46% -$15.7M 0.01% 192
2024
Q2 		$32.9M Buy
211,150
+68,550
+48% +$10.3M 0.02% 178
2024
Q1 		$19.2M Sell
142,600
-6,300
-4% -$834K 0.01% 233
2023
Q4 		$20.1M Sell
148,900
-94,400
-39% -$12.3M 0.01% 226
2023
Q3 		$33M Sell
243,300
-475,300
-66% -$64.9M 0.02% 185
2023
Q2 		$103M Sell
718,600
-44,900
-6% -$6.61M 0.07% 92
2023
Q1 		$106M Buy
763,500
+264,500
+53% +$35.6M 0.08% 96
2022
Q4 		$67.7M Buy
499,000
+44,750
+10% +$5.61M 0.07% 110
2022
Q3 		$50.2M Buy
454,250
+33,000
+8% +$4.19M 0.04% 95
2022
Q2 		$55.4M Sell
421,250
-170,450
-29% -$22.4M 0.06% 73
2022
Q1 		$78.5M Sell
591,700
-456,050
-44% -$54.7M 0.08% 61
2021
Q4 		$124M Buy
1,047,750
+586,650
+127% +$69M 0.11% 60
2021
Q3 		$55.4M Buy
461,100
+201,050
+77% +$23.4M 0.05% 73
2021
Q2 		$31.2M Buy
+260,050
New +$28.5M 0.04% 78
2021
Q1 		– Hold
0
– – – 74

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Optiver Holding's AZN Position: Q2 2026 in Review

Optiver Holding reduced its AstraZeneca (AZN) stake by 5.5% in Q2 2026, selling an estimated $994K and leaving 90,150 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #348.

Optiver Holding first reported a position in AZN in Q1 2021 and has held it in 15 quarters since. The position peaked at $72.9M in Q4 2023. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Optiver Holding held 90,150 shares of AstraZeneca worth $17.1M as of Q2 2026.
  • Optiver Holding sold 5,283 AstraZeneca shares in Q2 2026, an estimated $994K.
  • AstraZeneca made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #348 holding.
  • Optiver Holding first reported a position in AstraZeneca in Q1 2021 and has held it in 15 quarters since.
  • Optiver Holding's AstraZeneca position peaked at $72.9M in Q4 2023.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.